Efficacy and safety of repetitive transcranial magnetic stimulation in the treatment of autism: a randomized controlled trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039366

Enrollment

Unknown

Registered

2020-10-24

Start date

2020-11-20

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Interventions

Repetitive transcranial magnetic stimulation group:Repetitive transcranial magnetic stimulation (rTMS) with continuous ? short array fast pulse (cTBS) mode

sham repetitive transcranial magnetic stimulation group:sham repetitive transcranial magnetic stimulation group

Eligibility

Sex/Gender

All

Age

4 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1. According to the diagnostic and Statistical Manual of mental disorders (dsm-5) ASD diagnostic criteria; 2. Subjects aged from 4 to 10 years.

Exclusion criteria

Exclusion criteria: 1. Patients with other mental diseases; 2. Patients with inherited metabolic diseases; 3. Patients with history of epilepsy and family history of epilepsy; 4. Patients with severe neurological diseases and history of craniocerebral trauma; 5. Patients with metal implants in the body.

Design outcomes

Primary

Measure	Time frame
autism behavior checklist;Clancy Behavior Scale;The Children's Sleep Habits Questionnaire;Parenting Stress Index;	—

Countries

China

Contacts

Public ContactZhou Xiaoqin

Anhui Medical University

zhouxqlulu@126.com+86 13865913378

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026